Work

TBXT expression in development and cancer: signaling, enhancers and epigenetics

Year: 2026
Type: article
Abstract: The transcription factor TBXT plays a pivotal role in vertebrate embryogenesis and has emerged as a key regulator in some cancers. During embryonic development, TBXT governs notochord differentiation and posterior body elongation, with its expression tightly controlled by signaling pathways including Nodal/Activin, bone morphogenetic protein (BMP), fibroblast growth factor (FGF), WNT, and retinoic acid (RA). These pathways act through conserved and species-specific cis-regulatory elements (CREs) that integrate activating and repressive inputs to ensure precise spatiotemporal expression. Beyond development, TBXT is aberrantly expressed in multiple cancers and functions in a context-dependent manner, acting as a driver in chordoma and promoting metastasis and poor prognosis in epithelial cancers such as triple-negative breast and non-small cell lung cancer, while exerting a protective role in glioma. Its dysregulation is influenced by signaling pathways including FGF, phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), transforming growth factor β (TGF-β), WNT, and hypoxia, and by epigenetic mechanisms. Notably, a super-enhancer downstream of TBXT drives its expression in chordoma, but the specific CREs that drive expression in other cancers remain uncharacterized. Elucidating how signaling pathways and CREs interact to regulate TBXT expression may offer avenues for targeted therapeutic interventions in cancers dependent on TBXT.
Language: English
Open Access status: diamond
OpenAlex ID: W7236632926
FWCI:
Cites: 107
Cited by:
Related to: 10